A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to characterize the effect of itraconazole (Part 1) and rifampin (Part 2) on the single-dose pharmacokinetics (PK) of TAK-788 and its active metabolites (AP32960 and AP32914) in healthy adult participants.

Key facts

Study ID
NCT03928327
Run by
Millennium Pharmaceuticals, Inc.
People needed
24
Starts
2019-05-02
Expected to finish
2019-08-16
Last updated by the study team
2020-08-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.